Major drug study tracks Real-World eczema treatment results
NCT ID NCT05387980
Summary
This study is monitoring the safety and effectiveness of CIBINQO tablets for treating atopic dermatitis (eczema) in real-world Japanese medical practice. It involves over 1,100 participants who are prescribed this medication as part of their regular treatment. The research tracks side effects, treatment discontinuations, and improvements in skin symptoms and itching over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Local Country Office
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.